Search

everythinglearnresearchcommunity

for

Search:↓

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Dab2 protein is crucial for hair follicle stem cell renewal and preventing early aging.

Kojyl cinnamate ester derivatives can promote hair growth by increasing adiponectin production in fat tissues.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Presurgical models can effectively and affordably screen cancer prevention agents.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Imuvert can prevent some chemotherapy-induced hair loss.

Scientists can control how skin stem cells divide by using different treatments.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Hedgehog pathway inhibitors could be effective in treating melanoma.

Overexpressing COX-2 in mice skin reduces skin tumor development.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Antioxidants can block the cancer-fighting effects of doxorubicin.

A new compound may treat benign prostatic hyperplasia better than finasteride.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.